Dual BET/HDAC inhibition to relieve neuropathic pain: recent advances, perspectives, and future opportunities.
Sign Up to like & getrecommendations! Published in 2021 at "Pharmacological research"
DOI: 10.1016/j.phrs.2021.105901
Abstract: Despite the intense research on developing new therapies for neuropathic pain states, available treatments have limited efficacy and unfavorable safety profiles. Epigenetic alterations have a great influence on the development of cancer and neurological diseases,… read more here.
Keywords: dual bet; activity; neuropathic pain; bet hdac ... See more keywords